Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
0.769
+0.037 (5.03%)
At close: Nov 22, 2024, 4:00 PM
0.799
+0.030 (3.96%)
After-hours: Nov 22, 2024, 7:21 PM EST
Seres Therapeutics Market Cap
Seres Therapeutics has a market cap or net worth of $130.82 million as of November 22, 2024. Its market cap has decreased by -17.05% in one year.
Market Cap
130.82M
Enterprise Value
157.60M
1-Year Change
-17.05%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since June 26, 2015, Seres Therapeutics's market cap has decreased from $1.88B to $130.82M, a decrease of -93.06%. That is a compound annual growth rate of -24.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 139.00M | -23.20% |
| Dec 29, 2023 | 181.00M | -74.06% |
| Dec 30, 2022 | 697.70M | -8.81% |
| Dec 31, 2021 | 765.10M | -65.78% |
| Dec 31, 2020 | 2.24B | 825.71% |
| Dec 31, 2019 | 241.50M | 30.75% |
| Dec 31, 2018 | 184.70M | -55.06% |
| Dec 29, 2017 | 411.00M | 2.88% |
| Dec 30, 2016 | 399.50M | -70.85% |
| Dec 31, 2015 | 1.37B | -27.26% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seer, Inc. | 143.29M |
| Acumen Pharmaceuticals | 142.39M |
| Elutia | 140.33M |
| TriSalus Life Sciences | 138.12M |
| Vaxart | 136.46M |
| Ventyx Biosciences | 130.81M |
| Vigil Neuroscience | 130.26M |
| Innate Pharma | 128.92M |